Cemex SAB de CV Financials
Cemex SAB de CV (CX) reported $16.1B in revenue for fiscal year 2025, down 0.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Strong cash generation has funded a multi-year deleveraging, even while revenue stayed roughly flat and near-term liquidity remained tight.
The most revealing pattern is FY2023's profit trough: net income fell to$199M even as operating cash flow reached$2.2B . Because free cash flow was still$1.4B then and net margin returned to6.0% by FY2025, that dip looks more like an earnings-line distortion than a breakdown in the core cash engine.
Across FY2021-FY2025, balance-sheet repair was substantial, with long-term debt dropping from
The business still runs with tight short-term liquidity: the current ratio stayed below 1.0x in every reported year and sat at 0.8x in FY2025. That matters less than it would for a weak cash generator because operating cash flow of
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Cemex SAB de CV's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Cemex SAB de CV, and counted as zero in the overall score.
Cemex SAB de CV's revenue declined 0.4% year-over-year, from $16.2B to $16.1B. This contraction results in a growth score of 28/100.
Cemex SAB de CV carries a low D/E ratio of 0.10, meaning only $0.10 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 80/100, indicating a strong balance sheet with room for future borrowing.
Cemex SAB de CV's current ratio of 0.83 is below the typical benchmark, resulting in a score of 13/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Cemex SAB de CV has a free cash flow margin of 6.4%, earning a moderate score of 54/100. The company generates positive cash flow after capital investments, but with room for improvement.
Not available for Cemex SAB de CV, and counted as zero in the overall score.
Cemex SAB de CV passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Cemex SAB de CV generates $2.04 in operating cash flow ($2.0B OCF vs $970.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Cemex SAB de CV generated $16.1B in revenue in fiscal year 2025. This represents a decrease of 0.4% from the prior year.
Cemex SAB de CV reported $970.0M in net income in fiscal year 2025. This represents an increase of 1.0% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Cemex SAB de CV generated $1.0B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 15.0% from the prior year.
Cemex SAB de CV held $1.8B in cash against $1.4B in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Cemex SAB de CV's net profit margin was 6.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.1 percentage points from the prior year.
Cemex SAB de CV's ROE was 7.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.6 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
Cemex SAB de CV invested $947.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 5.3% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
CX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.1B-0.4% | $16.2B-2.1% | $16.6B+12.6% | $14.7B+2.3% | $14.4B+13.5% | $12.7B-2.2% | $13.0B-4.2% | $13.5B+4.7% | $12.9B | N/A |
| Interest Expense | $72.0M-2.7% | $74.0M+5.7% | $70.0M+12.9% | $62.0M-7.5% | $67.0M-9.5% | $74.0M-3.9% | $77.0M+4.1% | $74.0M+4.2% | $71.0M | N/A |
| Income Tax | $385.0M+474.6% | $67.0M-94.4% | $1.2B+616.7% | $168.0M+22.6% | $137.0M+280.6% | $36.0M-77.1% | $157.0M-29.9% | $224.0M+1300.0% | $16.0M | N/A |
| Net Income | $970.0M+1.0% | $960.0M+382.4% | $199.0M-77.5% | $885.0M+13.8% | $778.0M+153.8% | -$1.4B-907.8% | $179.0M-68.6% | $570.0M-34.3% | $867.0M | N/A |
| EPS (Diluted) | $0.01 | $0.02 | $0.00-72.9% | $0.01 | $0.02+157.3% | -$0.03 | $0.00 | $0.01-21.6% | $0.01 | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income.
CX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $28.9B+6.0% | $27.3B-4.0% | $28.4B+7.5% | $26.4B-0.8% | $26.6B-2.8% | $27.4B-6.6% | $29.4B+0.6% | $29.2B-2.4% | $29.9B | $29.8B |
| Current Assets | $6.1B+21.6% | $5.0B+0.2% | $5.0B+10.6% | $4.5B+7.1% | $4.2B-0.2% | $4.2B-7.5% | $4.6B+33.8% | $3.4B-5.9% | $3.6B | $4.3B |
| Cash & Equivalents | $1.8B+110.9% | $864.0M+38.5% | $624.0M+26.1% | $495.0M-19.2% | $613.0M-35.5% | $950.0M+20.6% | $788.0M+155.0% | $309.0M-55.8% | $699.0M | $561.0M |
| Inventory | $1.5B+2.8% | $1.5B-17.0% | $1.8B+7.2% | $1.7B+32.4% | $1.3B+29.9% | $971.0M-1.8% | $989.0M-8.5% | $1.1B+12.7% | $959.0M | N/A |
| Goodwill | $7.2B-3.6% | $7.4B-3.0% | $7.7B+1.8% | $7.5B-5.6% | $8.0B-6.1% | $8.5B-11.0% | $9.6B-3.5% | $9.9B-0.4% | $9.9B | $10.0B |
| Total Liabilities | $15.3B+3.3% | $14.8B-9.2% | $16.3B+5.0% | $15.5B-5.1% | $16.4B-11.3% | $18.5B-0.4% | $18.5B+2.3% | $18.1B-6.0% | $19.3B | $20.4B |
| Current Liabilities | $7.3B+20.6% | $6.1B-10.2% | $6.8B+22.4% | $5.5B+3.1% | $5.4B+0.5% | $5.4B-1.1% | $5.4B+12.8% | $4.8B-18.8% | $5.9B | $4.3B |
| Long-Term Debt | $1.4B-75.0% | $5.5B-11.2% | $6.2B-10.7% | $7.0B-5.5% | $7.4B-21.0% | $9.3B-0.3% | $9.4B+0.6% | $9.3B-5.7% | $9.9B | $11.4B |
| Total Equity | $13.6B+9.3% | $12.5B+3.0% | $12.1B+11.1% | $10.9B+6.2% | $10.3B+14.7% | $9.0B-17.3% | $10.8B-2.1% | $11.1B+4.3% | $10.6B | $9.5B |
| Retained Earnings | $6.1B+15.8% | $5.2B+18.5% | $4.4B+4.3% | $4.2B+25.3% | $3.4B+28.6% | $2.6B+62.6% | $1.6B-0.1% | $1.6B+45.5% | $1.1B | $829.0M |
Not reported in any period shown, so not listed: Accounts Receivable.
CX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.0B+4.3% | $1.9B-14.8% | $2.2B+62.4% | $1.4B-25.8% | $1.8B+15.6% | $1.6B+17.6% | $1.4B-13.5% | $1.6B-15.1% | $1.8B | N/A |
| Capital Expenditures | $947.0M-5.3% | $1.0B+15.6% | $865.0M+14.6% | $755.0M-2.7% | $776.0M+44.2% | $538.0M-17.4% | $651.0M+8.3% | $601.0M+6.0% | $567.0M | N/A |
| Free Cash Flow | $1.0B+15.0% | $894.0M-34.1% | $1.4B+121.4% | $613.0M-42.5% | $1.1B+1.0% | $1.1B+50.0% | $704.0M-27.1% | $966.0M-24.4% | $1.3B | N/A |
| Investing Cash Flow | -$197.0M+39.9% | -$328.0M+75.2% | -$1.3B-106.6% | -$640.0M-134.4% | -$273.0M-413.8% | $87.0M+133.2% | -$262.0M+67.9% | -$815.0M-247.4% | $553.0M | N/A |
| Financing Cash Flow | -$796.0M+36.5% | -$1.3B-78.7% | -$701.0M+27.1% | -$961.0M+48.1% | -$1.9B-21.8% | -$1.5B-151.7% | -$604.0M+48.1% | -$1.2B+51.3% | -$2.4B | N/A |
| Dividends Paid | $127.0M+41.1% | $90.0M | N/A | N/A | N/A | N/A | $150.0M | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | $111.0M | $0-100.0% | $83.0M+66.0% | $50.0M-33.3% | $75.0M | N/A | N/A |
CX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 6.0%+0.1pp | 5.9%+4.7pp | 1.2%-4.8pp | 6.0%+0.6pp | 5.4%+16.8pp | -11.4%-12.8pp | 1.4%-2.8pp | 4.2%-2.5pp | 6.7% | N/A |
| Return on Equity | 7.1%-0.6pp | 7.7%+6.0pp | 1.6%-6.5pp | 8.1%+0.5pp | 7.6%+23.7pp | -16.2%-17.8pp | 1.7%-3.5pp | 5.1%-3.0pp | 8.2% | N/A |
| Return on Assets | 3.4%-0.2pp | 3.5%+2.8pp | 0.7%-2.7pp | 3.4%+0.4pp | 2.9%+8.2pp | -5.3%-5.9pp | 0.6%-1.3pp | 1.9%-1.0pp | 2.9% | N/A |
| Current Ratio | 0.830.0x | 0.82+0.1x | 0.74-0.1x | 0.820.0x | 0.790.0x | 0.79-0.1x | 0.85+0.1x | 0.71+0.1x | 0.62 | 0.99 |
| Debt-to-Equity | 0.10-0.3x | 0.44-0.1x | 0.51-0.1x | 0.64-0.1x | 0.72-0.3x | 1.04+0.2x | 0.870.0x | 0.84-0.1x | 0.93 | 1.20 |
| FCF Margin | 6.4%+0.9pp | 5.5%-2.7pp | 8.2%+4.0pp | 4.2%-3.3pp | 7.4%-0.9pp | 8.3%+2.9pp | 5.4%-1.7pp | 7.1%-2.7pp | 9.9% | N/A |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin.
Note: The current ratio is below 1.0 (0.83), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where Cemex SAB de CV Ranks
Frequently Asked Questions
What is Cemex SAB de CV's annual revenue?
Cemex SAB de CV (CX) reported $16.1B in total revenue for fiscal year 2025. This represents a -0.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Cemex SAB de CV's revenue growing?
Cemex SAB de CV (CX) revenue declined by 0.4% year-over-year, from $16.2B to $16.1B in fiscal year 2025.
Is Cemex SAB de CV profitable?
Yes, Cemex SAB de CV (CX) reported a net income of $970.0M in fiscal year 2025, with a net profit margin of 6.0%.
How much debt does Cemex SAB de CV have?
As of fiscal year 2025, Cemex SAB de CV (CX) had $1.8B in cash and equivalents against $1.4B in long-term debt.
What is Cemex SAB de CV's net profit margin?
Cemex SAB de CV (CX) had a net profit margin of 6.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Cemex SAB de CV's return on equity (ROE)?
Cemex SAB de CV (CX) has a return on equity of 7.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Cemex SAB de CV's free cash flow?
Cemex SAB de CV (CX) generated $1.0B in free cash flow during fiscal year 2025. This represents a 15.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Cemex SAB de CV's operating cash flow?
Cemex SAB de CV (CX) generated $2.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Cemex SAB de CV's total assets?
Cemex SAB de CV (CX) had $28.9B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Cemex SAB de CV's capital expenditures?
Cemex SAB de CV (CX) invested $947.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Cemex SAB de CV's current ratio?
Cemex SAB de CV (CX) had a current ratio of 0.83 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Cemex SAB de CV's debt-to-equity ratio?
Cemex SAB de CV (CX) had a debt-to-equity ratio of 0.10 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Cemex SAB de CV's return on assets (ROA)?
Cemex SAB de CV (CX) had a return on assets of 3.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Cemex SAB de CV's Piotroski F-Score?
Cemex SAB de CV (CX) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Cemex SAB de CV's earnings high quality?
Cemex SAB de CV (CX) has an earnings quality ratio of 2.04x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Cemex SAB de CV?
Cemex SAB de CV (CX) scores 29 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.